Lapatinib and letrozole as first-line therapy for metastatic breast cancer: Case report of bone metastasis 18 years later

Gabriella Mariani, Francesca Ricchini, Lorenzo Sica, Giulia Valeria Bianchi

Research output: Contribution to journalArticlepeer-review

Abstract

We describe a 63-year-old woman with a diagnosis of breast cancer who relapsed with multiple bone lesions 18 years later. The biological characteristics were estrogen receptor positive, progesterone receptor positive, and HER2-positive cancer. Lapatinib and letrozole was the treatment of choice as a manageable and active first-line therapy for this patient. Copyright - Il Pensiero Scientifico Editore.

Original languageEnglish
JournalTumori
Volume99
Issue number6
DOIs
Publication statusPublished - Nov 2013

Keywords

  • Breast cancer
  • Lapatinib
  • Letrozole
  • Metastases

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Lapatinib and letrozole as first-line therapy for metastatic breast cancer: Case report of bone metastasis 18 years later'. Together they form a unique fingerprint.

Cite this